JCJasper Callemeyn

Jasper Callemeyn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jasper Callemeyn has a total of 196 co-authors. Here are the top co-authors by number of shared publications:

  • Maarten Naesens

    Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium

    25 shared publications
  • Elisabet Van Loon

    Department of Microbiology, Immunology and Transplantation, Nephrology and Kidney Transplantation Research Group, KU Leuven, Leuven, Belgium; Department of Nephrology and Kidney Transplantation, University Hospital Leuven, Leuven, Belgium

    13 shared publications
  • Aleksandar Senev

    Department of Surgery, Comprehensive Transplant Center, Northwestern University, Chicago, USA

    12 shared publications
  • Dirk Kuypers

    Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    10 shared publications
  • Dirk Kuypers

    Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    9 shared publications
  • Evelyne Lerut

    Department of Morphology and Molecular Pathology, University Hospitals Leuven, Leuven, Belgium

    9 shared publications

Latest Publications

  • Open Access

    Multi-omic factor analyses uncovered cross-compartment complexity of biological processes in kidney transplantation

    by Claire Tinel, Alexis Varin, Dany Anglicheau, Jasper Callemeyn, Jetty De Loor, Wilfried Gwinner, Pierre Marquet, Marion Rabant, Virginia Sauvaget, Elisabet Van Loon, et al.


  • Open Access

    FCGR3A F158V Genotype Accelerates Progression to Chronic Alloimmune Injury in Antibody-Mediated Kidney Transplant Rejection: A Population-Based Cohort Study

    by Thomas Vanhoutte, Karolien Wellekens, Priyanka Koshi, Jasper Callemeyn, Evert Cleenders, Angelica Paglizazzi, Elisabet Van Loon, Thibaut Vaulet, Brendan Keating, Alice Koenig, et al.

    Background: Evidence for involvement of NK cells and monocytes as prime agents in the process of human kidney transplant rejection is expanding quickly. These cells express FCGR3A, used for antibody-dependent cellular cytotoxicity (ADCC) after engagement with donor-specific antibodies on graft cells. A functional genetic polymorphism in the Fc fragment of IgG IIIa receptor (CD16a) gene ( FCGR3A ) results in a high-affinity (V158 allele) or low-affinity receptor (F158 allele). Methods: We studied the impact of the FCGR3A F158V genotype on graft histology, function, and outcomes in a large, unselected observational cohort study of 1259 kidney transplants (40% F/F158, 46% F/V158 and 14% V/V158) with 5435 post-transplant transplant biopsies. Results: Presence of at least one V158 allele was proportionally and significantly associated with a lower rate of C4d without rejection (F/V158, HR=0.51 [0.29-0.92], p=0.026; V/V158, HR=0.28 [0.08-0.90], p=0.033). Additionally, V/V158 was strongly associated with chronic active antibody-mediated rejection (HR=9.13 [1.89–44], p=0.006) and transplant glomerulopathy (HR=1.67 [1.01–2.75], p=0.046). The V/V158 genotype significantly associated with accelerated graft functional decline (−1.68 mL/min/y versus −0.74 mL/min/y (F/F158), p=0.034) and a higher rate of graft failure (HR=1.49 [1.01-2.20], p=0.045). This association was driven by transplants with post-transplant rejection. Conclusions: Our findings suggest that FCGR3A affinity is key in AMR pathobiology. Low affinity of this receptor (F158 allele) might associate with abrogation of effective downstream ADCC, even in the presence of complement activation (C4d deposition), while high affinity of this receptor (V158 allele) might escalate AMR, accelerating evolution to more chronic AMR phenotypes (transplant glomerulopathy). This framework provides an immunobiological link between lower C4d without rejection rates, higher chronic active AMR/ transplant glomerulopathy rates and adverse graft outcomes associated with the FCGR3A V/V158 genotype. Key study findings: V/V158 associates with higher rates of chronic active AMR/transplant glomerulopathy, and lower rates of C4d without rejection V/V158 drives faster graft decline and graft failure, especially in transplants complicated with rejection FCGR3A F158V might link complement activation and ADCC in AMR pathobiology, accelerating chronic alloimmune injury

  • Open Access

    Identification and Cross-Platform Validation of Sparse Molecular Classifiers for Antibody-Mediated and T-Cell–Mediated Rejection After Kidney Transplantation

    by Jasper Callemeyn, Josué Manik Nava-Sedeño, Dany Anglicheau, Jack Beadle, Jan Hinrich Bräsen, Marian C. Clahsen-Van Groningen, Iacopo Cristoferi, Henriette de Loor, Andreas Deutsch, Marie Essig, et al.


  • Open Access

    Active immunologic participation and metabolic shutdown of kidney structural cells during kidney transplant rejection

    by Elisabet Van Loon, Baptiste Lamarthée, Jasper Callemeyn, Imane Farhat, Priyanka Koshy, Dany Anglicheau, Pietro Cippà, Amelie Franken, Wilfried Gwinner, Dirk Kuypers, et al.


  • Open Access

    Probable antibody-mediated rejection in kidney transplantation is a rare and challenging phenotype to define: Findings from a single-center study

    by Karolien Wellekens, Maarten Coemans, Jasper Callemeyn, Evert Cleenders, Tim Debyser, Steffi De Pelsmaeker, Marie-Paule Emonds, Priyanka Koshy, Dirk Kuypers, Angelica Pagliazzi, et al.


  • Sensitive HLA antibody testing and the risk of antibody‐mediated rejection and graft failure

    by Tim Debyser, Jasper Callemeyn, Maarten Coemans, Johan Kerkhofs, Priyanka Koshy, Dirk Kuypers, Aleksandar Senev, Anat R. Tambur, Elisabet Van Loon, Karolien Wellekens, et al.

    Solid phase detection and identification of HLA antibodies in kidney transplantation currently relies on single antigen bead (Luminex®) assays, which is more sensitive than the previously used enzyme‐linked immunosorbent assays (ELISA). To evaluate the impact of more sensitive HLA testing on antibody‐mediated rejection (AMR) occurrence and allograft survival, we analysed 1818 renal allograft recipients transplanted between March 2004 and May 2021. In 2008, solid phase testing switched from ELISA to Luminex. We included 393 (21.6%) transplantations before and 1425 (78.4%) transplantations after transition from ELISA‐ to Luminex‐based testing. For this study, bio‐banked ELISA era samples were tested retrospectively with Luminex. Significantly less pretransplant DSA were found in patients transplanted with pre‐existing HLA antibodies in the Luminex (109/387) versus the ELISA period (43/90) (28% vs. 48%, p < 0.01). Throughout histological follow‐up, 169 of 1818 (9.3%) patients developed AMR. After implementing Luminex‐based testing, the rate of AMR significantly decreased (p = 0.003). However, incidence of graft failure did not significantly differ between both eras. In conclusion, less patients with pretransplant DSA were transplanted since the implementation of Luminex HLA testing. Transition from ELISA‐ to Luminex‐based HLA testing was associated with a significant decrease in AMR occurrence post‐transplantation. Since the decline of AMR did not translate into improved graft survival, Luminex‐based testing has the added value of preventing low‐risk AMR cases. Therefore, Luminex' high sensitivity must be balanced against waiting time for a suitable organ.


  • Open Access

    The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection

    by Thibaut Vaulet, Jasper Callemeyn, Baptiste Lamarthée, Asier Antoranz, Tim Debyser, Priyanka Koshy, Dany Anglicheau, Jill Colpaert, Wilfried Gwinner, Philip F. Halloran, et al.

    Key Points: The estimated composition of immune cells in kidney transplants correlates poorly with the primary rejection categories defined by Banff criteria. Spatial cell distribution could be coupled with a detailed cellular composition to assess causal triggers for allorecognition. Intragraft CD8temra cells showed strong and consistent association with graft failure, regardless of the Banff rejection phenotypes. Background: The link between the histology of kidney transplant rejection, especially antibody-mediated rejection, T-cell–mediated rejection, and mixed rejection, and the types of infiltrating immune cells is currently not well charted. Cost and technical complexity of single-cell analysis hinder large-scale studies of the relationship between cell infiltrate profiles and histological heterogeneity. Methods: In this cross-sectional study, we assessed the composition of nine intragraft immune cell types by using a validated kidney transplant–specific signature matrix for deconvolution of bulk transcriptomics in three different kidney transplant biopsy datasets ( N =403, N =224, N =282). The association and discrimination of the immune cell types with the Banff histology and the association with graft failure were assessed individually and with multivariable models. Unsupervised clustering algorithms were applied on the overall immune cell composition and compared with the Banff phenotypes. Results: Banff-defined rejection was related to high presence of CD8 + effector T cells, natural killer cells, monocytes/macrophages, and, to a lesser extent, B cells, whereas CD4 + memory T cells were lower in rejection compared with no rejection. Estimated intragraft effector memory–expressing CD45RA (TEMRA) CD8 + T cells were strongly and consistently associated with graft failure. The large heterogeneity in immune cell composition across rejection types prevented supervised and unsupervised methods to accurately recover the Banff phenotypes solely on the basis of immune cell estimates. The lack of correlation between immune cell composition and Banff-defined rejection types was validated using multiplex immunohistochemistry. Conclusions: Although some specific cell types ( FCGR3A + myeloid cells, CD14 + monocytes/macrophages, and NK cells) partly discriminated between rejection phenotypes, the overall estimated immune cell composition of kidney transplants was ill-related to main Banff-defined rejection categories and added to the Banff lesion scoring and evaluation of rejection severity. The estimated intragraft CD8temra cells bore strong and consistent association with graft failure and were independent of Banff-grade rejection.


  • Top Cited Papers

    SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys

    by Shikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco, Anna Rinaldi, Alex Rajewski, Jasper Callemeyn, Elisabet Van Loon, Baptiste Lamarthée, Ambart Ester Covarrubias, Jean Hou, et al.

    The steps governing healing with or without fibrosis within the same microenvironment are unclear. After acute kidney injury (AKI), injured proximal tubular epithelial cells activate SOX9 for self-restoration. Using a multimodal approach for a head-to-head comparison of injury-induced SOX9 lineages, we identified a dynamic SOX9 switch in repairing epithelia. Lineages that regenerated epithelia silenced SOX9 and healed without fibrosis (SOX9 on-off ). By contrast, lineages with unrestored apicobasal polarity maintained SOX9 activity in sustained efforts to regenerate, which were identified as a SOX9 on-on Cadherin6 pos cell state. These reprogrammed cells generated substantial single-cell WNT activity to provoke a fibroproliferative response in adjacent fibroblasts, driving AKI to chronic kidney disease. Transplanted human kidneys displayed similar SOX9/CDH6/WNT2B responses. Thus, we have uncovered a sensor of epithelial repair status, the activity of which determines regeneration with or without fibrosis.


  • Top Cited Papers
    Open Access

    The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics

    by Maarten Naesens, Candice Roufosse, Mark Haas, Carmen Lefaucheur, Roslyn B. Mannon, Benjamin A. Adam, Olivier Aubert, Georg A. Böhmig, Jasper Callemeyn, Marian Clahsen-Van Groningen, et al.